Drug-food interactions can increase or decrease drug effects, resulting in therapeutic failure or toxicity. Activities that reduce these interactions play an important role for clinical pharmacists. This study was planned and performed in order to determine the role of clinical pharmacist in the prevention of absorption drug-food interactions through educating the nurses in a teaching hospita...

OBJECTIVE To determine the influence of demographics on patient preferences for community pharmacist attire. METHODS A 10-item questionnaire was developed and administered to patients visiting a chain pharmacy or an independent pharmacy in the Birmingham, Alabama metropolitan area. Mann-Whitney was used to examine if statistical differences existed in chain versus independent pharmacy patient...

OBJECTIVE To compare the effectiveness of an evidence-based, systematic approach to hypertension care involving comanagement of patients by primary care physicians and clinical pharmacists versus usual care in reducing blood pressure in patients with uncontrolled hypertension. METHODS Patients in a staff model medical group with uncontrolled hypertension were randomized to either a usual care...

drug-drug interactions (ddis) can lead to increased toxicity or reduction in therapeutic efficacy. this study was designed to assess the incidence of potential drug interactions (pdi) and rank their clinical value in post coronary care unit (post-ccu) of a teaching hospital in tehran, iran.in this prospective study, three pharmacists with supervision of a clinical pharmacist actively gathered n...

8 Abstract Background Medication reconciliation is a 9 basic principle of good medicines management. With the 10 establishment of the National Acute Medicines Programme 11 in Ireland, medication reconciliation has been mandated for 12 all patients at all transitions of care. The clinical pharmacist 13 is widely credited as the healthcare professional that plays 14 the most critical role in the ...

The American Society of Health-System Pharmacists (ASHP) believes that pharmacogenomic testing can improve medication-related outcomes across the continuum of care in all health-system practice settings. These improvements include reduction in suboptimal clinical outcomes, decreased cost of treatment, better medication adherence, more appropriate selection of therapeutic agents, decreased lengt...

The purpose of this report is to: 1) Identify linkages across the EPA statements, Center for the Advancement of Pharmacy Education 2013 Educational Outcomes (CAPE 2013) and the Joint Commission of Pharmacy Practitioners' Pharmacist Patient Care Process (PPCP); 2) Provide ways EPA statements can be used to communicate core skills that are part of the entry-level pharmacist identity; 3) Suggest a...

To reveal any potential bias in this publication, and in accordance with Accreditation Council for Continuing Medical Education guidelines, Dr. Hocum (author) reports he is a stockholder and clinical pharmacist at Genelex Corporation. Dr. Kitzmiller (peer reviewer) reports he receives grant/research support from the National Institues of Health and is a retained consultant for Ohio Clinical Tri...

BACKGROUND prescribing for older people is a complex process and can elevate the risk of inappropriate prescribing, with potentially severe consequences. With a growing ageing population, strategies to improve prescribing in care homes are essential. Our aim was to review systematically the effects of interventions to optimise prescribing in care homes. METHOD databases searched were MEDLINE,...

The research pays more attention on evaluating the impact of patient education as directed by a clinical pharmacist concerning disease, useful effects treatment, causes life style modifications and finally improving quality patients diagnosed with Gastroesophageal reflux disease (GERD). It is prospective observational study, GSRS scores according to baseline, follow up1 up2 were 7.552 ± ...